A Review on Gold Nanoparticles (GNPs) and their Advancement in Cancer Therapy

<p>There are approximately 18 million cancer cases have been observed per year worldwide according to Global cancer therapy (GLOBOCAN). Chemotherapy, radiotherapy and surgery have been mostly used for cancer therapy. The maximum tolerated dose is currently being used to cure patients. The inco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shabbir Hussain (Autor), Muhammad Amjad (Autor)
Format: Llibre
Publicat: International Journal of Nanomaterials, Nanotechnology and Nanomedicine - Peertechz Publications, 2021-01-19.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-3492_000040
042 |a dc 
100 1 0 |a Shabbir Hussain  |e author 
700 1 0 |a Muhammad Amjad  |e author 
245 0 0 |a A Review on Gold Nanoparticles (GNPs) and their Advancement in Cancer Therapy 
260 |b International Journal of Nanomaterials, Nanotechnology and Nanomedicine - Peertechz Publications,   |c 2021-01-19. 
520 |a <p>There are approximately 18 million cancer cases have been observed per year worldwide according to Global cancer therapy (GLOBOCAN). Chemotherapy, radiotherapy and surgery have been mostly used for cancer therapy. The maximum tolerated dose is currently being used to cure patients. The incorporated advancement of modern nanoparticle-based techniques will be important to find one of the main issues in both radiotherapy and chemotherapy: normal tissue toxicity. The Gold Nanoparticle (GNP) based systems are very helpful to further improve chemotherapy by controlled releases of chemotherapeutics, but local radiotherapy dose can be improved through targeting the GNPs to the tumor. Over 20 nanotechnology-based therapeutic products have been authorized for clinical use in the past two decades. The main purpose of this review article is to understand how we can accelerate the clinical use of GNP-based therapeutic system to reduce normal tissue toxicity while increasing the worth of the treatment. Nanomedicines will change future cancer treatment methods in a better way that has minimum side effects. </p> 
540 |a Copyright © Shabbir Hussain et al. 
546 |a en 
655 7 |a Review Article  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-3492.000040  |z Connect to this object online.